Integrin targeting using RGD-PEI conjugates for in vitro gene transfer

被引:210
作者
Kunath, K
Merdan, T
Hegener, O
Häberlein, H
Kissel, T
机构
[1] Univ Marburg, Dept Pharmaceut & Biopharm, D-35032 Marburg, Germany
[2] Univ Marburg, Dept Pharmaceut Biol, D-35032 Marburg, Germany
关键词
gene delivery; polyethylenimine; integrins; RGD peptides; PEG; targeting;
D O I
10.1002/jgm.382
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Targeting to integrin receptor alpha(upsilon)beta(3) by RGD peptides seems to be a promising approach for gene delivery to proliferating endothelial cells of tumor metastases. PEGylation of cationic polymers offers a reduction of non-specific binding to cell surfaces. However, little knowledge exists on the influence of charge shielding by PEGylation on targeted gene delivery. Therefore, a variety of RGD peptide-polyethylenimine (PEI) conjugates with different degrees of substitution, with or without poly(ethylene glycol) (PEG) spacer, were synthesized. influence of degree of substitution and PEG spacer on physicochemical properties as well as on integrin targeting of DNA/polymer complexes was evaluated. Methods The tetrapeptide RGDC was coupled to PEI with or without a PEG spacer. Complex formation with DNA was monitored by ethidium bromide (EtBr) fluorescence quenching. Hydrodynamic diameters of complexes and zeta-potential were assessed using a Zetasizer. Fluorescence correlation spectroscopy (FCS) was used to determine peptide binding to living cells. Transfection efficiency was evaluated employing a luciferase reporter gene. Binding of complexes to Mewo cells was monitored by flow cytometry. Results Polyplexes of RGD-PEI or RGD-PEG-PEI and DNA showed reduced quenching of EtBr fluorescence compared with PEI. All RGD conjugates formed small polyplexes (approximately 100 nm in diameter at a nitro gen/phosphate (N/P) ratio of 6.7). At N/P = 6.7, the zeta-potentials of RGD-PEI complexes were similar to PEI complexes (25-30 mV), while RGD-PEG-PEI formed neutral complexes. FCS showed saturable binding of RGD peptide to Mewo human melanoma cells and only low binding to A549 human lung carcinoma cells. A degree of substitution of 4.6% with SPDP as coupling reagent yielded a conjugate showing 50 times higher luciferase expression in Mewo cells than unmodified PEI at low N/P ratios around 3.3, while a degree of substitution of 1.6% only led to a moderately increased transfection efficiency. Flow cytometry experiments suggest that this effect is partly caused by increased attachment of complexes to cell surfaces. No improvement in transfection. efficiency was found in alpha(nu)beta(3)-negative A549 cells. RGD-PEG-PEI complexes showed reasonable transfection efficiencies at high N/P ratios; however, no targeting effect could be found. Conclusions Coupling of the tetrapeptide RGDC without a PEG spacer improved transfection efficiency of PEI in integrin-expressing Mewo cells by 1-2 orders of magnitude, especially at low N/P ratios. The use of a PEG spacer seems to impair targeting, possibly by not only shielding PEI, but also the RGD ligand. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:588 / 599
页数:12
相关论文
共 45 条
  • [1] Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery
    Blessing, T
    Kursa, M
    Holzhauser, R
    Kircheis, R
    Wagner, E
    [J]. BIOCONJUGATE CHEMISTRY, 2001, 12 (04) : 529 - 537
  • [2] Evidence for specific interactions between kavain and human cortical neurons monitored by fluorescence correlation spectroscopy
    Boonen, G
    Pramanik, A
    Rigler, R
    Häberlein, H
    [J]. PLANTA MEDICA, 2000, 66 (01) : 7 - 10
  • [3] A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE
    BOUSSIF, O
    LEZOUALCH, F
    ZANTA, MA
    MERGNY, MD
    SCHERMAN, D
    DEMENEIX, B
    BEHR, JP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) : 7297 - 7301
  • [4] Efficient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection
    Diebold, SS
    Lehrmann, H
    Kursa, M
    Wagner, E
    Cotten, M
    Zenke, M
    [J]. HUMAN GENE THERAPY, 1999, 10 (05) : 775 - 786
  • [5] Erbacher P, 1999, J GENE MED, V1, P210
  • [6] Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway
    Erbacher, P
    Remy, JS
    Behr, JP
    [J]. GENE THERAPY, 1999, 6 (01) : 138 - 145
  • [7] FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
  • [8] Polyethylenimine-based intravenous delivery of transgenes to mouse lung
    Goula, D
    Benoist, C
    Mantero, S
    Merlo, G
    Levi, G
    Demeneix, BA
    [J]. GENE THERAPY, 1998, 5 (09) : 1291 - 1295
  • [9] Guo WJ, 1999, AAPS PHARMSCI, V1
  • [10] HART SL, 1995, GENE THER, V2, P552